Myraqa Has Joined Illumina

Thank you for visiting Myraqa. 

If you haven't heard our big news, Myraqa has been acquired by Illumina

Since 1998, it has been our priviledge and pleasure to contribute to many efforts to advance the state of diagnostic technology. Joining Illumina will allow us to continue to make those contributions, albeit in a deeper and more specific way.

Illumina will honor Myraqa's service obligations and we foresee no need for disruption to any current projects. 

We're still in the industry and we look forward to seeing you at conferences and meetings just as we always have before.

Thank you for your interest and support.

Recent Blog Posts

The Staple That Changed an Industry LDT regulation and the perils of challenging Eminem to a rap battle
FDA Releases the Kraken Whichever way this breaks, it's long past time to have this conversation in a meaningful way
Illumina Acquires Myraqa Acquisition Strengthens Illumina’s Clinical Readiness
The Spirit of GLP A Best Practice for IVDs
Process Performance Qualification (PPQ) Lots So, how many lots are required?
The Case for Risk-based Monitoring Better the devil you know...
Form Follows Function OIR Reorganizes to Meet the Advancing Wave of Molecular Diagnostics
CDRH Unveils New PMA Guidance Documents Attention shoppers, it's two-for-one day!